Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Site News

Added 9 hours ago Drug news

FDA approves Zolgensma to treat spinal muscular atrophy .- Novartis

AveXis, a Novartis company, announced that the FDA has approved Zolgensma (onasemnogene abeparvovac-xioi), one-time dose of gene therapy , for...

Added 9 hours ago Drug news

FDA approves Piqray + fulvestrant to treat hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-), PIK3CA-mutated, advanced or metastatic breast cancer.- Novartis

Novartis announced the FDA has approved Piqray (alpelisib, formerly BYL 719) in combination with fulvestrant for the treatment of postmenopausal...

Added 1 day ago Drug news

Pooled phase III data with Xeljanz shows changes that could correlate with CV risk in psoriatic arthritis .- Pfizer

To investigate the CV risk factors and major adverse cardiovascular events (MACE) in patients with active Psoriatic Arthritis (PsA) receiving...

Added 1 day ago Drug news

Chiesi Farmaceutici licences Raxone for the treatment of Leber's Hereditary Optic Neuropathy worldwide except in US and Canada. Santhera Pharma

Santhera Pharmaceuticals announces that it has entered into an exclusive license agreement with Chiesi Farmaceutici, an international research-focused healthcare group...

Added 1 day ago Drug news

OPTION trial initiated to compare WATCHMAN FLX left atrial appendage closure platform to first-line oral anticoagulants

Boston Scientific Corporation has initiated the OPTION trial to compare safety and effectiveness of the next-generation WATCHMAN FLX left atrial...

Added 1 day ago Drug news

Stryker secures FDA PMA for Neuroform Atlas brain aneurysm stent system.

Stryker announced that it has secured FDA premarket approval for its Neuroform Atlas stent system intended for use in treating...

Added 1 day ago Drug news

Nektar Therapeutics announces formation of Inheris Biopharma Inc., a CNS focused company

Nektar Therapeutics announced the formation of Inheris Biopharma, Inc., a wholly-owned subsidiary of Nektar and a CNS-focused company. Inheris will...

Added 1 day ago Industry news

Merck Inc., acquires Peloton Therapeutics and with it PT 2977 , a novel oral HIF-2 alpha inhibitor to treat renal cell carcinoma

Merck Inc., known as MSD outside the United States and Canada, and Peloton Therapeutics, Inc. announced that the companies have...

Added 2 days ago Drug news

Phase III APeX-2 trial of BCX 7353 reported data for treatment of hereditary angioedema

BioCryst Pharmaceuticals, Inc. announced that the randomized (n=121), double-blind, placebo-controlled, Phase III APeX-2 trial of once-daily, oral BCX 7353 for...

Added 3 days ago Drug news

Phase II data annonuced for once-daily, fixed dose combination asthma treatment

Novartis announced that new phase II data for IND/GLY/MF (QVM 149), an investigational, once-daily, fixed dose combination asthma treatment containing...

Search all news articles